A New Era for Immunotherapeutic Approaches in Multiple Sclerosis Treatment

Journal of Clinical Trials
doi 10.4172/2167-0870.1000253
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

The New Era of Multiple Sclerosis Therapeutics

Neurotherapeutics
NeurologyPharmacology
2012English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

A New Biotherapeutic Approach for the Treatment of Multiple Sclerosis

Translational Medicine
2013English

A multicentRE Observational analysiS of PErsistenCe to Treatment in the New Multiple Sclerosis Era: The RESPECT Study

Journal of Neurology
Neurology
2018English

Immunotherapeutic Approaches for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Novel Immunotherapeutic Approaches for the Treatment of Acute Leukemia (Myeloid and Lymphoblastic)

Therapeutic Advances in Hematology
Hematology
2015English

Treatment Satisfaction in Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2014English

Natalizumab Treatment in Multiple Sclerosis

Clinical Neurology
Neurology
2015English

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy